Please login (Members) to view content or
(Nonmembers) this article.
5
Average: 5 (1 vote)
Advanced Practice
NCPD Article

Adrenal Insufficiency: Immune Checkpoint Inhibitors and Immune-Related Adverse Event Management

Kiera B. Hobbs
Susan Yackzan
CJON 2020, 24(3), 240-243 DOI: 10.1188/20.CJON.240-243

Adrenal insufficiency (AI) is a potential immune-related adverse event (irAE) of immunotherapy (e.g., checkpoint inhibitor). If not identified and treated promptly, AI can be life-threatening. Unlike other irAEs, AI may be irreversible, requiring long-term glucocorticoid and mineralocorticoid replacement. Provider and patient education are essential in the management of immune checkpoint inhibitor–induced AI.

AT A GLANCE

  • Treatment with immunotherapy may lead to irAEs, such as AI.
  • Glucocorticoid and mineralocorticoid replacement may be required in patients with AI.
  • To manage AI over time, advanced practice RNs must be aware of its signs and symptoms.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or